Literature DB >> 7148905

Leiomyosarcoma of the uterus.

T Van Dinh, J D Woodruff.   

Abstract

A series of 43 cases of uterine leiomyosarcoma was reviewed. Forty-one of the 43 patients were followed up 2 or more years. The overall 5-year survival was 73%. Favorable prognostic features included the premenopausal status of the patient, the confinement of the tumor within a myoma, the low mitotic count (less than four mitotic figures in any one high-power field or less than four mitotic figures per 10 high-power fields), the absence of necrosis, and the presence of hyalinization in the adjacent tissue suggesting confinement. Special cases such as those in which only myomectomy was performed and those receiving adjunctive chemotherapy are discussed. The differential in survival between patients with primary myosarcoma and those with lesions arising in a leiomyoma is stressed.

Entities:  

Mesh:

Year:  1982        PMID: 7148905     DOI: 10.1016/0002-9378(82)90358-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

2.  An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.

Authors:  Mary-Margaret L Allen; Jonathan J Douds; Sharon X Liang; Mohamed M Desouki; Vinita Parkash; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy.

Authors:  Michael J Strong; Trevor Rosenlof; Siddhartha Padmanabha; Roy S Weiner; Lee Roy Morgan; Marcus I Ware
Journal:  J Neurosurg Spine       Date:  2015-07-17

4.  [Relapsing uterine leiomyosarcoma: report of a case].

Authors:  Youssef Benabdejlil; Mohammed Elmarjany; Abdellah Babahabib; Mehdi Elhassani; Hafsa Chahdi; Jaouad Kouach; Driss Rahali Moussaoui; Mohammed Dehayni
Journal:  Pan Afr Med J       Date:  2014-09-24

5.  Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Leiomyosarcoma: 27 Years of Experience.

Authors:  R Rothmund; M Huebner; C Joachim; A Hartkopf; T Fehm; M Bamberg; M Wallwiener; S Brucker; F A Taran
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

6.  Uterine leiomyosarcoma in pregnancy.

Authors:  J S Younis; E Okon; S O Anteby
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

7.  Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.

Authors:  Klaus Bodner; Barbara Bodner-Adler; Oliver Kimberger; Klaus Czerwenka; Klaus Mayerhofer
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

Review 8.  Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature.

Authors:  Shane Corcoran; Aisling M Hogan; Tamas Nemeth; Fadel Bennani; Francis J Sullivan; Waqar Khan; Kevin Barry
Journal:  Diagn Pathol       Date:  2012-07-18       Impact factor: 2.644

9.  Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.

Authors:  Hitomi Tsukada; Toshinari Muramatsu; Masaki Miyazawa; Tetsuji Iida; Masae Ikeda; Masako Shida; Takeshi Hirasawa; Hiroshi Kajiwara; Masaru Murakami; Masanori Yasuda; Mikio Mikami
Journal:  Acta Histochem Cytochem       Date:  2012-04-21       Impact factor: 1.938

Review 10.  Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis.

Authors:  Hong Liu; Yi Zhu; Guo-Nan Zhang; Chang Wang; Chao Li; Yu Shi
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.